Period cycle is 22 days , 1st day of period is 12 july and leuprolide

Period cycle is 22 days , 1st day of period is 12 july and leuprolide 3.75 is given on 30 july and period comes on 7 August, the period flow is very less

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Searching the Web

leuprolide 3.75 depot flare effect withdrawal bleed light period cycle day 18

Now I have a thorough picture. Let me provide a detailed, well-reasoned analysis of this clinical scenario.

Clinical Analysis: Leuprolide 3.75 mg Depot + Menstrual Timing

Timeline Reconstruction

Event	Date	Day of Cycle
Period starts (Cycle Day 1)	12 July	Day 1
Leuprolide 3.75 mg depot given	30 July	Day 19
Next period arrives	7 August	8 days after injection
Expected period (22-day cycle)	~3 August	Day 22

What Happened - Step by Step

1. The Flare Effect (Days 1-7 post-injection)

When leuprolide depot is first given, it acts as a GnRH agonist for the first 7-10 days before pituitary downregulation kicks in. This initial flare transiently surges LH and FSH, which in turn briefly spikes estradiol and progesterone. In the luteal phase (Day 19 of a 22-day cycle is deep luteal phase), this added hormonal stimulation is quickly followed by a sharp drop as the pituitary begins to desensitize.

2. Why the Period Came on Day 8 Post-Injection (7 August)

The period was actually slightly delayed - normally due on approximately August 3rd (Day 22 = July 12 + 22 days). The August 7th bleed (Day 26) represents a pseudo-withdrawal bleed triggered by the rapid estrogen/progesterone drop as leuprolide transitions from its initial agonist flare into the suppression phase. The endometrium, already primed in the late luteal phase, sheds when hormones fall.

3. Why the Flow is Very Light

This is the key and expected finding. The official prescribing information for Lupron Depot 3.75 mg confirms:

"LUPRON DEPOT 3.75 mg monthly induced amenorrhea in 74% of patients after the first treatment month and 98% after the second month. Most of the remaining patients reported episodes of only light bleeding or spotting."

The light flow here is because the GnRH agonist has already begun suppressing the HPO axis. Pituitary GnRH receptors are starting to downregulate, reducing FSH/LH, which reduces ovarian estradiol. Less estradiol = thinner endometrium = less blood during shedding. This is not pathological - it is the expected pharmacological effect of the drug.

Summary of Why Each Event Occurred

Observation	Explanation
Period came (didn't miss it entirely)	Injection given Day 19 - too late in the cycle to prevent this bleed; full suppression takes time
Period slightly delayed (Aug 7 vs expected Aug 3)	Leuprolide flare briefly extended corpus luteum function, delaying endometrial shedding by ~4 days
Flow very light	GnRH suppression already partially reducing estradiol - endometrium thinner than usual

What to Expect Next

The next period (September) will likely be absent or extremely minimal - leuprolide will have achieved full pituitary downregulation by then
By Month 2, ~98% of women are in amenorrhea
This is the intended therapeutic effect (for endometriosis, fibroids, IVF prep, or similar indication)
Hot flashes, vaginal dryness, and mood changes may begin over the next few weeks as the hypoestrogenic state becomes established (- Berek & Novak's Gynecology, management of endometriosis section)

When to Be Concerned

The scenario described is normal and expected. However, flag for clinical review if:

Heavy bleeding persists beyond 7-10 days
Pelvic pain significantly worsens
No amenorrhea develops after the 2nd month
Signs of infection at injection site

The light period on August 7th is essentially the last bleed before amenorrhea sets in - a reassuring sign that the drug is working as intended.

On d2 ultrasound for fet transfer the endometrium is 8 but period flow is very less ,then what can do now

Finding Sources

Searching the Web

FET frozen embryo transfer day 2 ultrasound endometrium 8mm light period leuprolide what to do next

Finding Sources

Searching the Web

day 2 FET baseline ultrasound endometrium 8mm after leuprolide GnRH agonist - is it too thick to start estrogen?

Excellent - I now have all the information needed for a thorough answer.

Day 2 Baseline Ultrasound for FET: Endometrium 8 mm + Light Period

First - Understanding the Context

This is a GnRH agonist downregulated FET cycle (leuprolide 3.75 mg given Day 19 of previous cycle). The period that came on Aug 7 is Day 1 of the FET prep cycle. Today (Day 2), the ultrasound shows an endometrium of 8 mm with very light flow.

Is 8 mm on Day 2 Baseline a Problem?

Yes - it is too thick for a true baseline. The standard requirement for a Day 2 baseline scan before starting estrogen priming in an artificial FET cycle is:

Endometrium: < 4-5 mm (thin, shed lining confirming adequate suppression)
No dominant follicle (ovaries quiet)
This confirms the uterus has fully shed and is ready to respond to exogenous estrogen

An 8 mm endometrium on Day 2 means:

The endometrium has not fully shed - the very light period confirms this. The leuprolide has already begun suppressing the cycle, so the endometrial shedding is incomplete (the lining did not get the normal full hormonal withdrawal that drives proper menstruation).
There may still be residual endometrial tissue from the previous cycle.
Trilaminar/organized pattern at this stage may indicate retained secretory or proliferative tissue.

What Can Be Done - Step by Step

Option 1: Wait and Repeat Scan in 2-3 Days (First Choice)

Allow the light period to complete over the next few days.
Repeat ultrasound on Day 4-5 of the cycle.
In many cases the thin shedding will continue and the endometrium will drop to ≤ 4 mm.
Only start estradiol once the endometrium is confirmed thin (< 4-5 mm) and the bleed has settled.

Option 2: Check Hormone Levels NOW

Order on the same day:

Serum E2 (estradiol) - should be low (< 50 pg/mL) to confirm adequate leuprolide suppression
LH - should be suppressed (< 2 IU/L)
Progesterone - should be < 1 ng/mL
FSH - should be low

If E2 is elevated or LH is not suppressed → leuprolide effect is incomplete → the thick endometrium may reflect residual ovarian activity → do not start estrogen yet.

Option 3: If Endometrium Remains Thick by Day 5-7

Consult your IVF specialist about continuing leuprolide at a low maintenance dose (0.5-1 mg/day) and waiting another week before re-scanning.
Some protocols add a GnRH antagonist (e.g., cetrorelix 0.25 mg) if leuprolide suppression is incomplete.
A short course of progesterone withdrawal (norethindrone or medroxyprogesterone for 5 days) can sometimes help shed the residual endometrium before re-starting the cycle.

Option 4: If Endometrium Drops to < 5 mm on Repeat Scan

Start oral estradiol valerate (Progynova) 2 mg twice or three times daily as standard FET estrogen priming, beginning on whatever day the lining is confirmed thin.
As noted in published FET protocols, estrogen is started on the 1st or 2nd day of the cycle with the aim of endometrial proliferation - but only once the baseline lining is confirmed thin.
If the lining hasn't shed by Day 5-7 → cycle may need to be cancelled and restarted.

Key Decision Tree

Day 2: Endometrium 8 mm + light period
           |
    Check E2, LH, Progesterone
           |
    ┌──────────────────────────────┐
    │                              │
Hormones suppressed          Hormones not suppressed
(E2 < 50, LH < 2)           (E2 raised, LH >2)
    │                              │
Wait 2-3 days + rescan      Leuprolide ineffective →
    │                       increase dose / add antagonist
    │
Endometrium < 5 mm?
    |          |
   YES         NO
    |          |
Start       Cancel cycle or
estrogen    progesterone
            withdrawal +
            restart next cycle

Summary

Finding	Meaning	Action
8 mm on Day 2	Incomplete shedding due to leuprolide suppression	Do NOT start estrogen yet
Very light flow	Expected with GnRH agonist (as discussed in previous analysis)	Reassuring - suppression working
Target before starting estrogen	< 4-5 mm endometrium	Recheck on Day 4-5
Minimum for FET transfer (later)	≥ 8 mm	Already at threshold - once shed and re-primed, this patient is likely a good responder

The good news: This patient has already shown she can build an 8 mm lining even with a suppressed cycle - once the leuprolide downregulation is confirmed and estrogen priming starts on a clean baseline, she should reach an excellent transfer lining of 8-10+ mm.

This analysis is for educational and clinical discussion purposes. The treating IVF specialist must make the final decision based on the full clinical picture, hormone assay results, and institutional protocol.

This is a shared conversation. Sign in to Orris to start your own chat.